Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Assay:
≥98% (HPLC)
Form:
powder
Quality Segment
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
-10 to -25°C
Application
Biochem/physiol Actions
GPX4 Inhibitor A16, equipped with a cysteine reactive warhead ynamide, is a highly potent and selective covalent inhibitor of glutathione peroxidase 4 (GPX4), surpassing existing inhibitors like ML210 and ML162 in its ability to induce ferroptosis in cancer cells through GPX4 inhibition. With its wide-ranging effectiveness across various cell lines (IC50: 0.02-0.2 μM) and significant in vivo (10 mg/kg, i.p., in AsPC-1 xenograft mouse model) anticancer activity coupled with a favorable safety profile, A16′s mechanism, verified by chemical proteomics and ferrostatin-1 rescue assays, demonstrates its considerable therapeutic potential by targeting the GPX4-dependent ferroptosis pathway.
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
Storage Class
11 - Combustible Solids
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
